Aktuella utlysningar, vecka 41, 2022
Grants Office tipsar om aktuella utlysningar
Svenska och nordiska anslag
Forskningsanslag – Wera Ekströms Stiftelse för pediatrisk forskning
Wera Ekströms Stiftelse för pediatrisk forskning inbjuder ansökningar om forskningsanslag. Dessa stöder pediatrisk forskning, i första hand med inriktning på de sjukdomstillstånd som drabbar ämnesomsättningen. Stiftelsen har ansökningstid vartannat år, jämna år.
Closing date: 1 november 2022
Research Grants – Medtech4Health – innovators in health and care
Vinnova, the Swedish Energy Agency and Formas invites application for grants to innovators in health and care from the program Medtech4Health. These support the development and commercialization of medical technical solutions in health care. The solutions may be a physical product, a service, a process or an organizational change and should aim to solve a defined challenge.
Grants are worth between SEK 300,000 and SEK 1m for up to two years. For projects applying for more than SEK 500,000 co-financing for the part above SEK 500,000 is required and must be at least 30 per cent. Grants cover costs for staff, depreciation costs for instruments, equipment and buildings, consults and licences, other direct costs such as material and travel and indirect costs.
Closing date: November 8, 2022
Forskningsanslag - Stiftelsen Apotekare Hedbergs fond för medicinsk forskning och Bertil och Ebon Norlins stiftelse för medicinsk forskning
Stiftelsen Apotekare Hedbergs fond för medicinsk forskning och Bertil och Ebon Norlins stiftelse för medicinsk forskning avser att dela ut sammanlagt cirka 2 000 000 kronor för avancerad medicinsk forskning i Sverige. Stiftelserna kommer att prioritera projekt inom områdena inflammatoriska sjukdomar och neurologiska sjukdomar. Beloppet kommer att fördelas mellan högst 10 sökanden.
Closing date: November 15, 2022
Stiftelsen Apotekare Hedbergs fond för medicinsk forskning (hedbergsstiftelse.se)
Norlins stiftelse för medicinsk forskning
Call for funding for educational support - SFO Stem cells and Regenerative medicine 2022-2023 – Karolinska Institutet
The SFO Stem cells and Regenerative medicine announces up to four educational grants to support regular seminar series or well-defined educational activities within the area of stem cells, regenerative medicine and cellular therapies. Eligible projects will be supported with a maximum of 200 000 SEK for 2023.
Closing date: November 15, 2022
Call for funding for educational support 2022-2023 | Karolinska Institutet (ki.se)
Announcement of seed funding within the field of oral health for collaboration with National Dental Centre Singapore
The internationalisation advisory council is pleased to announce the availability of limited competitive funds for grant applications to strengthen collaborative interactions within oral health and innovations. The funds are to be used as “seed grants” aiming at starting or sustaining bilateral collaborations with Singapore within the field of oral health innovations and biotechnologies, in order to address emerging issues in global health. The funding can be used to facilitate writing of joint applications to major granting agencies or be used for joint training of research staff and students.
Closing date: November 3, 2022
Utlysning: Eurolife Postdoc Mobility and Knowledge Exchange Grants 2023 (8th round)
Du som (junior) forskare vid KI är välkommen att söka medel från Eurolife för ett korttidsutbyte vid ett annat lärosäte inom nätverket. Inom satsningen på Eurolife Postdoc Mobility and Knowledge Exchange erbjuder Eurolife 9 bidrag för att stimulera ytterligare forskningssamarbete. Bidraget på 1500 EUR är för att täcka rese- och boendekostnader under en utbytesperiod som måste omfatta minst 2 veckor under perioden 1 mars - 31 december 2023.
Sista ansökningsdag: 30 November 2022
Mer information om utlysningen, villkor och ansökan finns på Eurolifes webbplats om Eurolife Postdoc Mobility and Knowledge Exchange
Europeiska anslag
International prize --Fyssen Foundation, FR
This recognises scientific inquiry into the development of computational approaches that advance the understanding of cognitive processes, which underlie animal and human behaviour, their biological and cultural bases, and phylogenetic and ontogenetic development.
Researchers may have a background in the fields of ethnology, psychology, neurobiology, human palaeontology or archaeology.
The prize is worth €100,000.
Closing date 14 November 2022
International grants -- Biocodex Microbiota Foundation, FR
These support clinical or fundamental research projects focused on human gut microbiota related to health and disease. For the current round, projects must focus on the new metabolites and small molecules, or novel functions of previously described metabolites, from gut microbiota that have an impact on gut mucosal pathways relevant to human health and disease.
Physicians, PhDs and doctors of pharmacy working in subject areas such as gastroenterology, paediatrics, microbiology, infectious diseases and internal medicine and based anywhere in the world may apply. Researchers must be affiliated with universities, hospitals or other research settings. Previous winners cannot apply anymore.
The grant is worth €200,000 over one to three years.
Closing date 30 November 2022
EFSD new targets for diabetes or obesity-related metabolic diseases -- European Association for the Study of Diabetes, EUR
This aims to stimulate and accelerate European research focusing on the identification and molecular understanding of new targets for the treatment of type 2 diabetes or obesity-related metabolic diseases. Areas of research emphasis may include:
•new targets for improving skeletal muscle or adipose tissue insulin resistance;
•the role of lipid droplets in the aetiology of metabolic fatty liver disease;
•mechanisms of glucose-dependent insulin and glucagon secretion;
•regulation of liver flat content by gut hormones or the microbiome.
Single non-profit institutions or groups of such institutions from Europe and associated countries may apply. Grants are worth up to €100,000 each for projects lasting one year or longer.
Closing date 1 December 2022
Accelerating new treatments versus arthritis -- Versus Arthritis, GB and other funders
This supports mechanistic experimental or translational medicine studies in humans across the areas of prevention, diagnosis or treatment that are aimed at priming the next transitional step. Studies can employ novel design, exploratory endpoints, biomarkers, imaging, big data or profiling or stratification approaches. Studies can also include digital technology solutions and account for co- or multi-morbidities. Applications are expected to have meaningful patient involvement as well as participation, from the beginning in terms of the design and delivery of the study.
Applications should involve at least two key organisations of the Musculoskeletal Translational Research Collaboration as a lead or co-applicant or collaborator. Studies are encouraged to include industry partners and international partners. At least one of the applicants must have a tenured position within a UK university, hospital or recognised academic research institute.
Grants are worth up to £300,000 each for up to three years.
Closing date 01 December 2022 (Forecast; we have no information from the funder yet about the next call. Based on past experience, we forecast the deadline to be around December 2022. This call is repeated once a year.)
Wolf Prize 2023
In accordance with the Wolf Prize principle of rotation, candidate(s) for the 2023 prize can be nominated in the following five fields:
Chemistry, Mathematics, Medicine, Agriculture, and Arts.
Attached you will find the formal nomination form for candidate’s submission.
Submission deadline: October 24th, 2022
Submission via email only to: Office@wolffund.org.il
Amerikanska anslag
Federal Funding agencies
Research grant, DoD Funding Opportunities for Toxic Exposure Research Program (TERP): Department of Defense
To meet the intent of the award mechanism, TERP applications must address at least one of the Program Goals listed below.
- Elucidate mechanisms of how toxic exposures result in adverse effects, including, but not limited to, toxicities, malignancies, neurologic and respiratory disorders, cardiac complications, sleep disorders, immune system dysfunction, gastrointestinal issues, etc.
- Diagnose the effects of toxic exposures, understand the phenotypic/genotypic and clinical outcomes associated with short-term and long-term exposures and predict disease progression.
- Predict and prevent toxic exposures by identifying strategies that can anticipate, identify, monitor and prevent Service Members and the American public from adverse effects of exposures to toxic substances.
- Develop therapeutics, treatments and strategies to minimize symptoms and disease progression associated with toxic exposures.
Deadlines: Investigator-Initiated Research Award; Translational Research Award; Clinical Trial Award – LOI due 3rd November, 2022 (5:00pm, ET); Full proposal due 1st December, 2022 (11:59pm, ET)
Basic/translational research on health disparities in underrepresented people living with HIV (PLWH) and cancer (R21 clinical trial not allowed): NIH
Through this new funding opportunity announcement (FOA), the National Cancer Institute (NCI) intends to focus on basic mechanistic and translational studies using the R21 grant mechanism to investigate HIV and cancer in underrepresented groups. In the context of this FOA, underrepresented groups include racial, ethnic, and gender minorities, including underserved minorities living in geographical areas that have high numbers of new HIV. Mechanistic and/or translational studies that examine how different comorbidities, associated behaviors, and other disorders contribute to the initiation, progression and disease sequelae in underserved populations may be proposed.
Deadline: December 15, 2022. Applications are due by 5:00 PM local time of applicant organization.
Funding Opportunity Announcement (FOA): RFA-CA-22-057
Immunity in Older Adults (U01 Clinical Trial Not Allowed): NIH
This Funding Opportunity Announcement (FOA) invites applicants to participate in the Immunity in Older Adults (65 years and older) cooperative agreement research program, which will focus on developing mechanistic insights into innate and adaptive immune function changes that occur during the aging process. The major goal of the program is to define the contribution of age-related alterations in different components of the immune system and the functional consequences in relation to infections, vaccine responses, and chronic inflammatory conditions.
Additionally, the program aims to foster collaborative science and establish innovative approaches that accelerate the discovery of cellular changes and the underlying molecular events occurring in the aging immune system that may potentially be exploited to improve the health of older adults.
Deadline: February 14, 2023. Applications are due by 5:00 PM local time of applicant organization.
Funding Opportunity Announcement (FOA): RFA-AI-22-060
NLM Research Grants in Biomedical Informatics and Data Science (R01 Clinical Trial Optional): NIH
The National Library of Medicine (NLM) supports innovative research and development in biomedical informatics and data science. This funding opportunity focuses on biomedical discovery and data-powered health, integrating streams of complex and interconnected research outputs that can be translated into scientific insights, clinical care, public health practices, and personal wellness. The scope of NLM's interest in these research domains is broad, with emphasis on new and innovative methods and approaches to foster data driven discovery in the biomedical and clinical health sciences as well as domain-independent, scalable, and reusable/reproducible approaches to discovery, curation, analysis, organization, and management of health-related digital objects.
Deadline: Standard dates apply. Applications are due by 5:00 PM local time of applicant organization.
Funding Opportunity Announcement (FOA): PAR-23-034
Foundations
CIPHER programme, International AIDS Society, INT
The International AIDS Society invites letters of intent for its research grants under its collaborative initiative for paediatric HIV education and research (CIPHER) programme. These support projects that address critical research questions that remain unanswered in the global response in order to inform policy change and ensure better outcomes in infants and children living with and affected by HIV in resource-limited settings. Projects should focus on operation science in paediatric HIV.
Eligibility: Applicants must have obtained their final research degree within the last 10 years.
Budget: Grants are each worth up to USD 150,000 for two years. Indirect costs are limited to 10%.
Deadline: LOI – 31st October 2022. Full application – 27th January 2023.
Career Development Award, Foundation Fighting Blindness, US
Career Development Award: The Foundation Fighting Blindness invites applications for its career development awards. These help advance junior clinical research scientists in their professional endeavours to cure retinal degenerative disease by facilitating advances in laboratory and clinical research; elucidating the mechanism for the cause and pathogenesis of retinal degenerative diseases; and developing innovative strategies to prevent, treat and cure these diseases. Eligibility: Clinician-scientists possessing an MD, DO, or recognised equivalent foreign degree and who are in their first, second, or third year of a junior faculty appointment, are eligible. Budget: Up to five awards, each worth USD 75,000 per year for five years (total $375,000), are available. Indirect costs are not covered. Deadline: Full application – 1st February 2023.
Individual Investigator/Clinical Innovation Awards: Individual Investigator Research Awards are designed to concentrate research in areas with the greatest potential to move toward treatments and cures for the inherited orphan retinal degenerative diseases and dry age-related macular degeneration. The Foundation Fighting Blindness will also award up to four Clinical Innovation Awards to advance options for endpoints in IRD clinical trials that might be accepted by regulatory agencies for improving IRD patients’ conditions or slowing disease progression. Eligibility: No restrictions. Budget: $300,000 over 3 years, annual budgets may not exceed a total of $100,000. Indirect costs are not covered. Deadline: LOI – 27th October 2022. Full application – 27th February 2023.
Further information
Discovery grant program, Leukemia & Lymphoma Society, US
The Leukemia and Lymphoma Society, in partnership with the Mark Foundation for Cancer Research and the Paul G Allen Frontiers Group, invites letters of intent for its discovery grant program. This supports research that is discovery oriented, concerned with understanding blood cancer properties and vulnerabilities and aimed toward advancing treatments for blood cancers. Examples of projects of potential interest include:
- cellular activities that underlie the behavior and vulnerabilities of blood cancer cells.
- resistance mechanisms including immune evasion, resistant clone evolution and cellular changes underlying development of resistance to chemotherapies.
- novel biomarkers or techniques to detect and monitor blood cancer development and progression.
- discovery of neoantigens, including those that may reside outside of coding regions.
- blood cancer cell interactions with the microenvironment and with the immune system, including exploration of novel immune synapses.
Eligibility: Applicants must be independent investigators, postdoctoral fellows are not eligible.
Budget: Budget cannot exceed $250,000 USD per year / $750,000 USD total for the 3 years of the grant. This budget ceiling includes all costs associated with the grant including indirect costs (10%).
Deadline: LOI – 4th November 2022. Full application – 3rd March 2023.
Research Grants, National Psoriasis Foundation, US
Translational Research grants: The National Psoriasis Foundation invites applications for its translational research grants. These support projects that focus on the rapid translation of basic scientific discoveries into clinical applications with a clear benefit for patients with psoriatic disease. Applications related to all aspects of psoriatic disease are strongly encouraged, including psoriatic arthritis and other comorbidities. Eligibility: No restrictions. Budget: Grants are worth up to USD 100,000 per year for up to two years, from 1 August 2023 to 31 July 2025. Indirect costs are not covered.
Discovery Research grants: The National Psoriasis Foundation invites applications for its discovery grants. Grants fund researchers while they explore preliminary ideas and conduct proof-of-concept experiments in the field of psoriatic disease. The goal is to stimulate the development of new research programs capable of competing for long-term funding from the National Institutes of Health or similar agencies in the future. Applications related to all aspects of psoriatic disease are strongly encouraged, including basic science, translational research, technology, epidemiology, health services, and clinical research. Eligibility: No restrictions. Budget: Grants are worth up to USD 75,000 for up to one year, from 1 August 2023 to 31 July 2025. Indirect costs are not covered.
Deadline: Full application – 15th January 2023.